14.84 stock price up
Change
+ 0.14 (0.95%)
Volume
30,900
Exchange
NASDAQ
As of 3:59 PM ET on Apr 27, 2015
Delayed at least 20 minutes.
Provided by eSignal.
5.91 stock price up
Change
+ 0.09 (1.48%)
Volume
271,142
Exchange
TASE
As of 2:24 PM Israel Time on Apr 27, 2015
Delayed at least 20 minutes.
Provided by eSignal.
View all »Recent Releases

Apr 27, 2015
RedHill Biopharma Announces Completion of Patient Enrollment in a Phase III Study of RHB-105 for H. pylori Infection

Apr 21, 2015
RedHill Biopharma to Host First Quarter 2015 Financial Results Conference Call on April 30, 2015

Apr 16, 2015
RedHill Biopharma Receives Notice of Allowance for Additional U.S. Patent for RHB-105 H. pylori Bacterial Infection Treatment

View all »Upcoming Events & Presentations

Apr 30, 2015 at 9:00 AM
RedHill Biopharma - First Quarter 2015 Financial Results Conference Call

May 4, 2015 - May 6, 2015
BioNetwork Partnering Summit
Trump International Beach Resort Miami

May 10, 2015 - May 10, 2015
Oppenheimer 16th Annual Israeli Conference
David Intercontinental Hotel, Tel-Aviv

Investor Relations (US):

Lauren Glaser
Vice President
The Trout Group LLC
Direct: +1 646 378 2972
Cell: +1 215 740 8468
email: lglaser@troutgroup.com

Investor Relations (Israel):

Eran Gabay
Vice President & Managing Director
Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
Direct: +972 (0)3 6070 591
email: erang@gk-biz.com

General:

RedHill Biopharma Ltd.
21 Ha’arba’a St., Tel-Aviv 64739, Israel
Tel: +972 (0)3 541 3131
Fax: +972 (0)3 541 3144
email: info@redhillbio.com